Table 3.
Summary of genetic toxicity thresholds in vivo of ENU
| Reference | Animals | Tissue | Endpoint | PoD (mg/kg bw/d) | |
|---|---|---|---|---|---|
| NOGEL | BMDL | ||||
| Delft et al | lacZ transgenic mice | Intestine | lacZ gene mutation | 10 | 5.46 |
| Dlb-1 gene mutation | NTa | 1.55 | |||
| Spleen | lacZ gene mutation | 25 | 11.7 | ||
| Bhalli et al | C57BL/6 | Peripheral blood | Pig−a gene mutation RET | 10 | 1.46 |
| mice | Pig−a gene mutation RBC | 45 | 0.95 | ||
| Micronucleus RET | 10 | 4.03 | |||
| O'Brien et al | Muta™ mice | Testis | lacZ gene mutation | 2 | 1 |
| Dobo et al | SD Rat | Peripheral blood | Pig−a gene mutation | 0.25 | - |
Abbreviations: RBC red blood cell, RET reticulocytes, NOGEL no observed genotoxic effect level, BMDL the lower bound of benchmark dose
aNT: All model failed to fit ( P < 0.1)